Search

Displaying results 2361 - 2370 of 10000 in total

Drug
Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
go.drugbank.com/drugs/DB10600
ApprovedWithdrawn
Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. … In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques.
Mixtures: Medical Provider Single Use EZ Flu Shot Afluria 2016-2017
Drug
Follitropin
go.drugbank.com/drugs/DB00066
ApprovedInvestigational
Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. … Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).
Products: REKOVELLE 12mcg/0.36mL solution for Injection in pre-filled pen, GONAL-F® SOLUTION FOR INJECTION IN PRE-FILLED PEN
Drug
Eftrenonacog alfa
go.drugbank.com/drugs/DB11608
Approved
It was first approved by the FDA in March 2014 and later approved by the EMA in May 2016. … Eftrenonacog alfa is a long-acting recombinant fusion protein used in the treatment of hemophilia B.
Drug
Galcanezumab
go.drugbank.com/drugs/DB14042
ApprovedInvestigational
[L42060] It is unknown if galcanezumab has an effect on pregnancy outcomes. A pregnancy exposure registry has been established to evaluate the safety of this drug in pregnant women.[L42060] … [A33112] Galcanezumab was approved by the FDA in September 2018, and is indicated for the preventive treatment of migraine and the treatment of episodic cluster headache.
Products: EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED PEN 120 MG/ML, Pontevia 120 mg solution for injection in pre-filled pen
Drug
Neratinib
go.drugbank.com/drugs/DB11828
ApprovedInvestigational
Neratinib was approved in July 2017 for use as an extended adjuvant therapy in Human Epidermal Growth Factor Receptor 2 (HER2) positive breast cancer. … Neratinib is currently under investigation for use in many other forms of cancer.
Drug
Gadoquatrane
go.drugbank.com/drugs/DB33282
Approved
in the central nervous system and in the body. … [L63930] Bayer announced FDA approval of gadoquatrane on June 15, 2026, for use with MRI in adult and pediatric patients, including term neonates, to detect and visualize lesions with abnormal vascularity
Drug
Belimumab
go.drugbank.com/drugs/DB08879
ApprovedInvestigational
It is produced by recombinant DNA technology in a murine cell (NS0) expression system. … [L42630] Belimumab was first approved by the FDA on March 9, 2011,[A251495] making it the newest drug to be approved for the treatment of SLE in more than 50 years.
Target
Serine/threonine-protein kinase SIK2
go.drugbank.com/bio_entities/BE0009538
TargetHumans
Serine/threonine-protein kinase that plays a role in many biological processes such as fatty acid oxidation, autophagy, immune response or glucose metabolism (PubMed:23322770, PubMed:26983400). Phosphorylates 'Ser-794' of IRS1 in insulin...
Synonyms: SIK-2
Drug
Fenpropidin
go.drugbank.com/drugs/DB12728
ApprovedWithdrawn
Fenpropidin has been investigated for the treatment of Hernia.
Categories: Compounds used in a research, industrial, or household setting
Drug
Eslicarbazepine acetate
go.drugbank.com/drugs/DB09119
ApprovedInvestigational
Eslicarbazepine acetate is marketed as Aptiom in North America and Zebinix or Exalief in Europe. It is available in 200, 400, 600, or 800mg tablets that are taken once daily, with or without food. … Eslicarbazepine acetate (ESL) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled